摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(3aS,4R,10S,10aS)-2,6-diamino-10-hydroxy-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl N-(6-aminohexyl)carbamate | 1187089-12-8

中文名称
——
中文别名
——
英文名称
[(3aS,4R,10S,10aS)-2,6-diamino-10-hydroxy-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl N-(6-aminohexyl)carbamate
英文别名
——
[(3aS,4R,10S,10aS)-2,6-diamino-10-hydroxy-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl N-(6-aminohexyl)carbamate化学式
CAS
1187089-12-8
化学式
C16H30N8O3
mdl
——
分子量
382.466
InChiKey
SSMBIECTWWLMKI-CENBSLRLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -3
  • 重原子数:
    27
  • 可旋转键数:
    9
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    177
  • 氢给体数:
    6
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Maleimide Conjugates of Saxitoxin as Covalent Inhibitors of Voltage-Gated Sodium Channels
    摘要:
    (+)-萨克霉素是一种天然存在的胍类毒素,用作电压门控钠离子通道(Na(V)s)的强效、选择性和可逆抑制剂。通过全合成得到的这种毒素的修饰形式带有半胱氨酸反应的马来酰亚胺基团,发现这些修饰形式不可逆地抑制了在重组表达的野生型钠离子通道和海马神经细胞中钠离子的传导。我们的发现支持了一种共价蛋白质修饰机制,其中毒素结合到通道孔道先于马来酰亚胺对亲核氨基酸的烷基化。还包括生物正交反应基团的第二代马来酰亚胺毒素缀合物也被发现不可逆地阻断了通道功能;此类化合物在选择性标记钠离子通道(用于活细胞成像和/或蛋白质组学实验)的试剂方面具有潜在用途。
    DOI:
    10.1021/ja4019644
  • 作为产物:
    描述:
    三(三氟乙酸)硼烷三氟乙酸 作用下, 反应 20.0h, 以64%的产率得到[(3aS,4R,10S,10aS)-2,6-diamino-10-hydroxy-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl N-(6-aminohexyl)carbamate
    参考文献:
    名称:
    Maleimide Conjugates of Saxitoxin as Covalent Inhibitors of Voltage-Gated Sodium Channels
    摘要:
    (+)-萨克霉素是一种天然存在的胍类毒素,用作电压门控钠离子通道(Na(V)s)的强效、选择性和可逆抑制剂。通过全合成得到的这种毒素的修饰形式带有半胱氨酸反应的马来酰亚胺基团,发现这些修饰形式不可逆地抑制了在重组表达的野生型钠离子通道和海马神经细胞中钠离子的传导。我们的发现支持了一种共价蛋白质修饰机制,其中毒素结合到通道孔道先于马来酰亚胺对亲核氨基酸的烷基化。还包括生物正交反应基团的第二代马来酰亚胺毒素缀合物也被发现不可逆地阻断了通道功能;此类化合物在选择性标记钠离子通道(用于活细胞成像和/或蛋白质组学实验)的试剂方面具有潜在用途。
    DOI:
    10.1021/ja4019644
点击查看最新优质反应信息

文献信息

  • [EN] METHODS AND COMPOSITIONS FOR STUDYING, IMAGING, AND TREATING PAIN<br/>[FR] PROCÉDÉS ET COMPOSITIONS POUR ÉTUDIER, VISUALISER PAR IMAGERIE ET TRAITER LA DOULEUR
    申请人:UNIV LELAND STANFORD JUNIOR
    公开号:WO2010129864A9
    公开(公告)日:2012-03-08
  • METHODS AND COMPOSITIONS FOR STUDYING, IMAGING, AND TREATING PAIN
    申请人:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    公开号:US20160115173A1
    公开(公告)日:2016-04-28
    Saxitoxin analogue compounds, compositions, pharmaceutical compositions, methods of synthesis of saxitoxin analogues, methods of imaging, methods of treatment, including methods of treating pain, are provided. Saxitoxin (STX), gonyautoxin (GTX), and zetekitoxin, and variant STX compounds bind to sodium channels and are effective to reduce or block flow of sodium ions through such channels. Such channel block affects nerve and muscle action, and may be effective to reduce or block pain sensations, relax muscles, reduce muscle spasm, and reduce wrinkles. STX analogue binding to sodium channels may also be useful to locate, image, or mark sodium channels, and so be useful in studying sodium channels and sodium channel disorders, and in the diagnosis and treatment of patients suffering from sodium channel disorders. In embodiments, the variant STX compounds include conjugates having increased serum half-life as compared to STX when administered to a subject. In embodiments, the present disclosure provides a method for alleviating pain in a subject in need of treatment, the method comprising administering to the subject an effective amount of a saxitoxin analogue compound, or a pharmaceutically acceptable salt, isomer, tautomer or prodrug thereof, whereby pain in said subject is alleviated.
查看更多

同类化合物

苯丙腈,b-氟-a-羟基- 膝沟藻毒素4 膝沟藻毒素 VIII 膝沟藻毒素 V 膝沟藻毒素 III 膝沟藻毒素 II 膝沟藻毒素 I 去氨基甲酰石房蛤毒素 原膝沟藻毒素4 二乙酸贝毒素 {2-[(3aS,4R,6Z)-2-氨基-5,10,10-三羟基-6-亚氨基-9-(磺基氧基)-3a,4,5,6-四氢-3H,10H-吡咯并[1,2-c]嘌呤-4-基]-1,1-二羟基乙基}氨基磺酸 (3As,10As)-3Aa,4,9,10-四氢-2,6-二氨基-4a-[[(磺基氨基羰基)氧基]甲基]-1H,8H-吡咯并[1,2-c]嘌呤-9b,10,10-三醇 9-硫酸酯 GTX 3 Atelopidtoxin ((3aS,4R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl)methyl (2-aminoethyl)carbamate (3aS,4R,10S,10aR)-tert-butyl 2,6-bis((tert-butoxycarbonyl)imino)-4-((carbamoyloxy)methyl)-10-hydroxyoctahydropyrrolo[1,2-c]purine-1(8H)-carboxylate [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrol-1-yl]propanoylamino]ethyl]carbamate [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrolidin-1-yl]propanoylamino]ethyl]carbamate [2,6-diamino-4-[(1-amino-3-methyl-2-oxo-6-prop-1-en-2-ylcyclohex-3-en-1-yl)oxymethyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-3H-pyrrolo[1,2-c]purin-9-yl] hydrogen sulfate N-Sulfocarbamoylgonyautoxin 2 decarbamoyl-α-saxitoxinol [(3aS,4R,9S,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-3H-pyrrolo[1,2-c]purin-9-yl] hydrogen sulfate ditert-butyl (3aS,4R,10S,10aR)-4-[(4-methoxyphenyl)methoxymethyl]-2,6-bis[(2-methylpropan-2-yl)oxycarbonylimino]-3-methylsulfonyl-10-trimethylsilyloxy-4,8,9,10-tetrahydro-3aH-pyrrolo[1,2-c]purine-1,5-dicarboxylate [(3aS,4R,10S,10aS)-2,6-diamino-10-hydroxy-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl N-(6-aminohexyl)carbamate [(3aS,4R,9S,10R,10aS)-9,10-dihydroxy-6-[(2,2,2-trichloroacetyl)amino]-2-(2,2,2-trichloroethoxysulfonylamino)-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl carbamate (2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl N-[6-[4-[4-[2-[4-cyano-5-(dicyanomethylidene)-2,2-dimethylfuran-3-yl]ethenyl]-N-methylanilino]butanoylamino]hexyl]carbamate [(3aR,4R,9R,10aR)-2,6-diamino-10,10-dihydroxy-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate [(3aS,4R,9R,10aR)-2,6-diamino-10,10-dihydroxy-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methoxycarbonylsulfamic acid [(3aS,4S,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate [(3aS,4R,9S,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl] 4-(trifluoromethyl)benzoate 5-[6-[(2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methoxycarbonylamino]hexylcarbamoyl]-2-(2,7-difluoro-3-hydroxy-6-oxoxanthen-9-yl)benzoic acid (2-amino-10,10-dihydroxy-6-pentylimino-1,3a,4,5,8,9-hexahydropyrrolo[1,2-c]purin-4-yl)methyl N-(6-aminohexyl)carbamate (2,6-diamino-1,9,10-trihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl N-(3,4-dimethylpentan-2-yl)carbamate (2,6-diamino-1,10-dihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl N-[6-[6-(hexylamino)hexanoylamino]hexyl]carbamate (2,6-diamino-1,10-dihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl N-[6-[[6-(7-methyloctylamino)-6-oxohexanoyl]amino]hexyl]carbamate Saxitoxin p-bromobenzenesulfonate [(3aS,4R)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate alpha-Saxitoxinol (3aS)-2,6-diamino-4-methyl-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purine-10,10-diol [(3aS,4R,9R,10aS)-2-amino-5,10,10-trihydroxy-4-(hydroxymethyl)-6-imino-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl] hydrogen sulfate [(3aS,4R,9R)-2-amino-5,10,10-trihydroxy-6-imino-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate (2,6-diamino-1,10-dihydroxy-10-methyl-2,3,3a,4,8,9-hexahydropyrrolo[1,2-c]purin-4-yl)methyl N-propan-2-ylcarbamate (2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl N-[4-(2,5-dioxopyrrol-1-yl)phenyl]carbamate (2,6-diamino-1-hydroxy-10-methoxy-4,8,9,10-tetrahydro-3aH-pyrrolo[1,2-c]purin-4-yl)methyl N-propan-2-ylcarbamate (2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl N-[[4-[4-(4-methylpentan-2-ylcarbamoyl)benzoyl]phenyl]methyl]carbamate [(4R)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate (2,6-Diamino-1,9,10-trihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl carbamate gonyautoxin VI (2,6-diamino-10,10-dihydroxy-5-oxido-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-5-ium-4-yl)methyl carbamate [(3aS,4R,10aS)-2-amino-5,10,10-trihydroxy-6-imino-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate